What question did this study set out to answer?

The study aims to compare the clinicopathological, genetic, and prognostic differences between mucinous and non-mucinous lung adenocarcinomas.

July 26, 2026Insights into ImagingOpen Access

Radiological pure-solid appearance clinical stage I lung adenocarcinoma: a comparative study of mucinous and non-mucinous adenocarcinoma based on imaging features and survival outcomes

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial compares recurrence patterns and survival outcomes of mucinous versus non-mucinous adenocarcinomas, indicating distinct prognoses.

The study aims to compare the clinicopathological, genetic, and prognostic differences between mucinous and non-mucinous lung adenocarcinomas.
Retrospective evaluation of 579 patients with clinical stage I lung adenocarcinoma.
Comparison of clinicopathological, radiological, genetic characteristics, and recurrence patterns between subtypes.
Application of Kaplan-Meier curves and Cox proportional hazard models to assess survival.
Mucinous adenocarcinoma showed better 5-year RFS (86.9% vs 62.7%) and OS (97.1% vs 83.2%; p < 0.001).
Non-mucinous adenocarcinoma had a higher recurrence rate (38.5% vs 13.1%; p < 0.001).
Higher rates of brain metastasis were observed in the non-mucinous group (27.1% vs 0%; p = 0.024).

Li et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Randomized trial compares recurrence patterns and survival outcomes of mucinous versus non-mucinous adenocarcinomas, indicating distinct prognoses.